Ace Report Cover
AAOS2017: IA bupivacaine adminsitration on POD1 not benefical following TKA
Reprints
Cite This
Reprints
Cite This
AceReport Image
Arthroplasty
AAOS2017: IA bupivacaine adminsitration on POD1 not benefical following TKA
Contributing Authors

RJ McGill S Trainor W Fitz

50 patients scheduled for total knee arthroplasty were administered intraoperative pericapsular injection analgesia and standard medications and were randomized to either receive or not receive additional administration of intraarticular bupivacaine injection via a catheter on the first postoperative day. Groups demonstrated no significant differences in maximum pain scores or narcotic consumption within the first 48 hours postoperatively.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. AAOS2017: IA bupivacaine adminsitration on POD1 not benefical following TKA. ACE Report. 2017;7(3):46. Available from: https://myorthoevidence.com/AceReport/Report/aaos2017-ia-bupivacaine-adminsitration-on-pod1-not-benefical-following-tka

Copy Citation
Share this Ace Report